Gaucher Disease Clinical Trials

A listing of Gaucher Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 26 clinical trials
Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

record genetic mutation data from participants with Gaucher disease.

velaglucerase alfa
vpriv
  • 0 views
  • 21 Aug, 2021
  • 2 locations
A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease

The main aim of this study is to learn if velaglucerase alfa (VPRIV) improves growth and symptoms in participants under 5 years old with Gaucher disease. Symptoms will be checked with blood

velaglucerase alfa
vpriv
  • 0 views
  • 20 Jul, 2021
  • 1 location
World Data on Ambroxol for Patients With GD and GBA Related PD

and efficacy of ambroxol for patients with Gaucher disease (GD).

  • 0 views
  • 29 Apr, 2021
  • 2 locations
The GBA Multimodal Study in Parkinson's Disease

This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of advanced neuroimaging techniques called PET (positron emission tomography) to study the accumulation of the tau protein and the dysfunction of acetylcholine and …

  • 0 views
  • 16 Apr, 2021
  • 3 locations
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

Primary Objective: To assess prevalence of Gaucher disease (GD) diagnosed in pediatric patients presenting with unexplained splenomegaly (SMG) after exclusion of first intention-diagnoses

  • 0 views
  • 29 Jul, 2021
  • 1 location
Natural History of Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders

treatment. Patients of any age with Tay-Sachs disease, Sandhoff disease, GM1 gangliosidosis, or type 2 Gaucher disease may be eligible for this study. Participants will be admitted to the NIH

MRI
deficiency
  • 76 views
  • 24 Sep, 2021
  • 1 location